“I am always humbled to hear about the amazing research work happening in Manchester,” said Sharon. “Having a look at the National Biomarker Centre ...

One of my favorite poems when I was younger was Dylan Thomas’ “Do Not Go Gentle Into That Good Night,” a poem he wrote for his dying father urging him to ...

When discussing side effects from chronic myeloid leukemia (CML) treatment with the health care team, it is essential that patients state how their daily ...

Specific factors help determine whether patients with multiple myeloma are eligible for stem cell transplants. It’s important for patients with multiple ...

The FDA approved Augtyro for some with NTRK-positive solid tumors. The Food and Drug Administration (FDA) granted an accelerated approval to Augtyro ...

For certain patients with head and neck cancer, treatment with Opdivo and reirradiation led to better delayed progression.Among patients with recurrent head ...

The initial discussions with health care teams regarding treatment options, side effects and long-term expectations are key in navigating a chronic myeloid ...

The evidence for dabrafenib plus trametinib The National Institute for Health and Care Excellence (NICE) recommended the NHS offer dabrafenib plus ...

Receiving a diagnosis of chronic myeloid leukemia (CML) can be overwhelming, but there are questions patients can ask their clinicians to ensure they have ...

The Food and Drug Administration (FDA) has granted traditional approval to Retevmo (selpercatinib) for the treatment of adult and pediatric patients 2 years ...